Targeting triple-negative breast cancer: A clinical perspective.

Autor: Popovic LS; Department of Medical Oncology, Oncology Institute of Vojvodina, Sremska Kamenica, Serbia.; Faculty of Medicine, University of Novi Sad, Novi Sad, Serbia., Matovina-Brko G; Department of Medical Oncology, Oncology Institute of Vojvodina, Sremska Kamenica, Serbia., Popovic M; Department of Medical Oncology, Oncology Institute of Vojvodina, Sremska Kamenica, Serbia.; Faculty of Medicine, University of Novi Sad, Novi Sad, Serbia., Punie K; Department of General Medical Oncology and Multidisciplinary Breast Centre, Leuven Cancer Institute, University Hospitals Leuven, Leuven, Belgium., Cvetanovic A; Department for Oncology, Medical Faculty Nis, University of Nis, Nis, Serbia.; Clinic of Oncology, Clinical Centre Nis, Nis, Serbia., Lambertini M; Department of Internal Medicine and Medical Sciences (DiMI), School of Medicine, University of Genova, Genova, Italy.; Department of Medical Oncology, U.O.C Clinica di Oncologia Medica, IRCCS Ospedale Policlinico San Martino, Genova, Italy.

Publikováno v: Oncology research [Oncol Res] 2023 May 24; Vol. 31 (3), pp. 221-238. Date of Electronic Publication: 2023 May 24 (Print Publication: 2023).

COVID-19 vaccines and cancer patients: acceptance, attitudes and safety.

Autor: Matovina Brko G; Department for Medical Oncology, Oncology Institute of Vojvodina, Sremska Kamenica, Serbia., Popovic M, Jovic M, Radic J, Bodlovic Kladar M, Nikolic I, Vidovic V, Kolarov Bjelobrk I, Kukic B, Salma S, Litavski J, Petrovic N, Vranjkovic B, Roganovic T, Ruzic M, Dugandzija T, Popovic L

Publikováno v: Journal of B.U.ON. : official journal of the Balkan Union of Oncology [J BUON] 2021 Sep-Oct; Vol. 26 (5), pp. 2183-2190.

Neoadjuvant Pembrolizumab Plus Chemotherapy in Early-Stage Triple-Negative Breast Cancer: A Nationwide Retrospective Turkish Oncology Group Study.

Autor: Karci, Ebru¹ (AUTHOR) abilici@medipol.edu.tr, Bilici, Ahmet¹ (AUTHOR) omerfatih.olmez@medipol.com.tr, Bayram, Buket² (AUTHOR) bkuvvet@kuh.ku.edu.tr, Celayir, Melisa³ (AUTHOR) ozde.celayir@acibadem.com, Ozyurt, Neslihan⁴ (AUTHOR) neslihanozyurt@odu.edu.tr, Uluc, Başak Oyan³ (AUTHOR) basak.uluc@acibadem.com, Eken, Aynur⁵ (AUTHOR) ekenaynur@gmail.com, Basaran, Gul³ (AUTHOR) gul.basaran@acibadem.edu.tr, Demirci, Umut⁶ (AUTHOR) umut.demirci@memorial.com.tr, Kemal, Yasemin⁷ (AUTHOR) yasemin.kemal@medikalpark.com.tr, Oruncu, Mehmet Berk⁸ (AUTHOR) mboruncu@ankara.edu.tr, Olmez, Omer Fatih¹ (AUTHOR) abdullah.sakin@medipol.edu.tr, Selcukbiricik, Fatih² (AUTHOR) fselcukbiricik@kuh.ku.edu.tr, Korkmaz, Taner³ (AUTHOR) taner.korkmaz@acibadem.com, Erturk, Ismail⁹ (AUTHOR) ismail.erturk@sbu.edu.tr, Bilgetekin, Irem⁶ (AUTHOR) irem.bilgetekin@memorial.com.tr, Celik, Serkan¹⁰ (AUTHOR) celik.serkan@yeditepe.edu.tr, Turkel, Alper¹¹ (AUTHOR) alper.turkel@sbu.edu.tr, Alkan, Ali¹² (AUTHOR) alialkan@mu.edu.tr, Sakin, Abdullah¹ (AUTHOR) oyildiz@medipol.edu.tr

Publikováno v: Cancers. Oct2024, Vol. 16 Issue 19, p3389. 13p.

Small Molecule Therapeutics in the Pipeline Targeting for Triple-Negative Breast Cancer: Origin, Challenges, Opportunities, and Mechanisms of Action.

Autor: James, Nneoma¹ (AUTHOR) nneoma.james01@utrgv.edu, Owusu, Esther¹ (AUTHOR) esther.owusu01@utrgv.edu, Rivera, Gildardo² (AUTHOR) giriveras@ipn.mx, Bandyopadhyay, Debasish^1,3 (AUTHOR) debasish.bandyopadhyay@utrgv.edu

Publikováno v: International Journal of Molecular Sciences. Jun2024, Vol. 25 Issue 11, p6285. 25p.

Serbian consensus of neoadjuvant therapy for breast cancer: NeoPULSE.

Autor: Popovic L; Clinic for Medical Oncology, Institute of Oncology of Vojvodina, Sremska Kamenica, Serbia., Tomasevic Z, Stamatovic L, Markovic I, Matovina-Brko G, Buta M, Golubovic A, Selakovic V, Trifunovic J, Mutrezani Z, Ivanovic N, Nedovic J, Ninkovic S, Filipovic S, Cvetanovic A, Djordjevic N, Karanikolic A, Ivkovic-Kapic T, Vicko F

Publikováno v: Journal of B.U.ON. : official journal of the Balkan Union of Oncology [J BUON] 2018 Mar-Apr; Vol. 23 (2), pp. 522-532.